1. Heard Mr.G.Masilamani, learned Senior Counsel appearing for Mr.C.Mohan, learned counsel for the petitioner and Mr.S.Haja Mohideen Gisthi, learned Senior Central Government Standing Counsel appearing for the respondents.

2. Challenging the Notification dated 10.02.2011 issued by the 1st respondent in GSR No.82 (E) published in Gazette of India Extraordinary Part--II Section 3-sub-section (i), seeking to quash the same in so far as it relates to Item No.3 viz., Phenylpropanolamine with a direction to the respondents to review the prohibition after giving an opportunity to him, the petitioner has come up with the present writ petition.

3. Facts, in a nutshell run thus :

3(i). Chemical, Industrial & Pharmaceutical Laboratories of India, popularly known as CIPLA, the petitioner herein, was formed in the year 1935. It is among the largest pharmaceutical Companies in India with a gross annual turnover of more than Rs.5,000 crores per annum. In the year 1952, a research division was set up by the petitioner with the view to attain self-sufficiency in technological development and since then, the petitioner has been progressing steadily in pharmaceutical, medicinal and drug de